Iridocyclitis
Conditions
Interventions
40 eyes of 40 subjects with usual indication for intravitreal anti-VEGF injection 48 to 72 hours before vitrectomy, in order to reduce the occurrence of intraoperative hemorrhage. The study will be di
Procedure/surgery
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patients with indication for intravitreal anti-VEGF injection followed by vitrectomy to treat complications of diabetic retinopathy.
Exclusion criteria
Exclusion criteria: Glaucoma; previous or current history of uveitis; previous vitreoretinal surgery; patients who have contraindications to the use of anti-VEGF.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased eye inflammation in the agitated group in the laboratory, by measuring cytokine levels in aqueous humor using the Cytometric Bead Assay method;Increased eye inflammation in the agitated group in the laboratory, by measuring cytokine levels in aqueous humor using the Cytometric Bead Assay method | — |
Secondary
| Measure | Time frame |
|---|---|
| Não são esperados desfechos secundários | — |
Countries
Brazil
Contacts
Public ContactMichel Farah
Universidade Federal de São Paulo
Outcome results
None listed